Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Narula

Showing results (121-130 of 204) with videos related to

Pageof 21
Sort By:
Inflammatory Bowel Diseases|June 30, 2025
Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE TrialDhruv Ahuja, Sama Anvari, Emily C L Wong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2021
Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative ColitisNeeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
The American Journal of Gastroenterology|February 25, 2025
A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and PracticePeter W Huan, Akash Mehta, Emily C L Wong, et al.
The American Journal of Gastroenterology|December 10, 2024
Effectiveness of Ustekinumab for Patients With Moderate-to-Severe Ulcerative Colitis: A Multicenter Real-World Canadian StudyVirginia Solitano, Neeraj Narula, Christopher Ma, et al.
Gastroenterology|August 6, 2021
Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysisShailja C Shah, Adam Tepler, Cecilia P Chung, et al.
Journal of the Canadian Association of Gastroenterology|April 25, 2020
Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing EffectivenessPetros Zezos, Boyko Kabakchiev, Adam V Weizman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2021
ReplyEmily C L Wong, Parambir S Dulai, Neil K Sengupta, et al.
Alimentary Pharmacology & Therapeutics|November 1, 2020
Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remissionNeeraj Narula, Achuthan Aruljothy, Abdul-Aziz Alshahrani, et al.
Igie : Innovation, Investigation and Insights|July 3, 2026
Practices and perceptions of advanced endoscopic imaging techniques for colorectal neoplasia detection in patients with inflammatory bowel disease: report of a survey among Canadian inflammatory bowel disease specialistsLisa M A van Lierop, Rebecca Dang, Talat Bessissow, et al.
Inflammatory Bowel Diseases|January 16, 2021
Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane ReviewsNilesh Chande, Siddharth Singh, Neeraj Narula, et al.
Pageof 21

Showing results (121-130 of 204) with videos related to

Sort By:
Pageof 21
Inflammatory Bowel Diseases|June 30, 2025
Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE TrialDhruv Ahuja, Sama Anvari, Emily C L Wong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2021
Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative ColitisNeeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
The American Journal of Gastroenterology|February 25, 2025
A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and PracticePeter W Huan, Akash Mehta, Emily C L Wong, et al.
The American Journal of Gastroenterology|December 10, 2024
Effectiveness of Ustekinumab for Patients With Moderate-to-Severe Ulcerative Colitis: A Multicenter Real-World Canadian StudyVirginia Solitano, Neeraj Narula, Christopher Ma, et al.
Gastroenterology|August 6, 2021
Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysisShailja C Shah, Adam Tepler, Cecilia P Chung, et al.
Journal of the Canadian Association of Gastroenterology|April 25, 2020
Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing EffectivenessPetros Zezos, Boyko Kabakchiev, Adam V Weizman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2021
ReplyEmily C L Wong, Parambir S Dulai, Neil K Sengupta, et al.
Alimentary Pharmacology & Therapeutics|November 1, 2020
Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remissionNeeraj Narula, Achuthan Aruljothy, Abdul-Aziz Alshahrani, et al.
Igie : Innovation, Investigation and Insights|July 3, 2026
Practices and perceptions of advanced endoscopic imaging techniques for colorectal neoplasia detection in patients with inflammatory bowel disease: report of a survey among Canadian inflammatory bowel disease specialistsLisa M A van Lierop, Rebecca Dang, Talat Bessissow, et al.
Inflammatory Bowel Diseases|January 16, 2021
Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane ReviewsNilesh Chande, Siddharth Singh, Neeraj Narula, et al.
Pageof 21